To sum up, WT1 sequential monitoring was critical to predict relapse in AML patients after allo-HSCT, but whether sequential monitoring of WT1 could predict relapse of AML children after allo-HSCT was unclear. The gene discussed is WT1; the disease is acute myeloid leukemia.